Slovakia’s WTP Thresholds for Drug Reimbursement Evaluations – An Uncertain Future for Innovation
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
$2995
GlobalData takes a detailed look at the changing willingness-to-pay (WTP) thresholds for drug reimbursement evaluations in Slovakia, in the midst of regulatory uncertainty following the withdrawal of a proposed draft decree in May 2025, which would have drastically worsened the prospects for new innovative therapies in the country.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
See what our customers are saying
Related reports
View more Product Type reports
New
New
New